For example, we observed epigenetic regulation of methylation of probes and/or gene regions of ABL1, ABL2, MET, XRCC5, KIFC3, and TIMP. Similarly, we observed associations of expression of multiple GMDs with a probe in TGFBI, whose product has been associated with poor prognosis in colorectal cancer and is a predictive biomarker for dasatinib sensitivity [110, 111]. The gene discussed is ABL2; the disease is colorectal cancer.